Inogen (INGN)

The company develops, manufactures, markets, sells, and rents respiratory products. Its portable oxygen concentrator portfolio is central to the business and is aimed at helping patients receive long-term oxygen therapy in a form that can be used at home or while travelling. Inogen also offers broader respiratory health products, including the Simeox airway clearance system, the Inogen Voxi 5 stationary oxygen concentrator, and Aurora continuous positive airway pressure masks in the United States.

Inogen sells through multiple channels, including direct-to-consumer activity, business-to-business relationships, and rental arrangements. This model exposes the company to consumer demand, physician and provider recommendations, reimbursement rules, and durable medical equipment distribution practices. Because oxygen therapy is a regulated area of healthcare, product quality, service, documentation, and payer requirements are important parts of the business.

The company operates in a market shaped by ageing populations, chronic lung disease, hospital-to-home care trends, and the desire for devices that are smaller, lighter, and easier to use. Inogen’s distinguishing position is its long-standing emphasis on portable oxygen technology and patient mobility, supported by a broader respiratory product line that extends its relevance across home-based respiratory care.